News|Articles|November 5, 2025

Outsourcing Small Molecule Purification Processes

Key Takeaways

Outsourcing medium-complexity tasks enabled scientists to focus on core research, enhancing innovation and strategic drug development efforts.
Tasks such as cell line maintenance, QC assays, and routine chromatography were outsourced to improve overall efficiency.
The strategic reallocation of resources fostered an environment conducive to scientific breakthroughs and advancements in drug development.

A leading global pharmaceutical company needed to find new ways to help scientists focus more time and attention on innovation and strategic drug projects. Medium-complexity tasks, such as maintaining cell lines, performing QC assays, and conducting routine chromatography work, were outsourced, allowing scientists to focus on their core research while improving overall efficiency.

Newsletter

Stay at the forefront of biopharmaceutical innovation. Subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe

Related Content

Andrea Zobel and Marco Hogenboom of Cencora speak during an interview about radiopharmaceutical logistics, regulatory complexity, and supply chain coordination for advanced cancer therapies.

Outsourcing Small Molecule Purification Processes

Key Takeaways

Related Content

Supply Chain Execution in Radiopharma: The Industry’s Next Critical Challenge

Streamlining Procurement and Inventory Management Leads to Increased Productivity

Managing Risk and Minimizing the Complexity of Your Global Single-Use Supply Chain

Distribution Resilience: Meeting Global Demand and Delivering Faster, More Reliable Service